ao. Univ.-Prof. Talin Barisani Asenbauer, MD: "Towards an eye drop vaccine against Trachoma", Assoc. Prof. Ruth Herbst, PhD: "Signaling and Trafficking of MuSK: a receptor tyrosine kinase critical for synapse formation and causal to neuromuscular diseases"
Monday, March 13, 2017, 12.30 pm, Hygiene Institute, Lecture Hall 2, Kinderspitalgasse 15, Vienna IX
COLLOQUIUM IN PATHOPHYSIOLOGY, INFECTIOLOGY AND IMMUNOLOGY
Talin Barisani-Asenbauer has studied Medicine at the University of Vienna, Austria. She started her career in 1987 at the Department of Ophthalmology as scientific coworker and from 1990 to 1997 she completed her residency in ophthalmology with special emphasis on ocular immunology and infectiology. In 1997 she became senior staff member of the Department and the director of the Uveitis unit and the working group “ocular immunology & infectiology”. In 2001 she was awarded the habiliation degree by the University of Vienna, the topic of her habilitation thesis being `Molecular methods to identify microbes in ocular tissues´. In 2009 Talin Barisani-Asenbauer succeeded to obtain one of eight highly competitive peer-reviewed Laura Bassi Centre of Expertise grants.
OCUVAC was established at the Institute of Specific Prophylaxis & Tropical Medicine and aims at achieving a multidisciplinary understanding of trachoma and ocular immunity that underpins the more translational research in the centre, while having the potential for the discovery of innovative drug-delivery systems and ocular vaccines.
Ruth Herbst heads a research group at the Institute of Immunology focusing on receptor signaling and trafficking. She performed her Ph.D. thesis at the Research Institute of Molecular Pathology (IMP) in Vienna and the University of Sheffield, UK. Ruth Herbst joined the laboratory of Steve Burden at the Skirball Institute of Biomolecular Medicine (NYU Medical Center, New York) as postdoctoral fellow to work on signaling events during neuromuscular synapse formation. In 2002 she moved to the Center of Brain Research at the Medical University of Vienna to establish an independent research group.
Within the last years Ruth Herbst has continued to work on the molecular mechanisms involved in neuromuscular synapse development. More recently, receptor endocytosis and trafficking has become a central research interest of her laboratory. Ruth Herbst joined the Center of Pathophysiology, Infectiology and Immunology in 2013.
Host: Hannes Stockinger
back to: CePII